Roswell Park at ASCO

Friday, May 30, 2025

• Zunairah Shah, MD, is first and presenting author, Abstract 1036 - Racial and ethnic disparities in clinical outcomes of HER2-positive metastatic breast cancer treated with antibody-drug conjugates: A TriNetX real-world evidence study.
  • 2:45 p.m. - Hall D2

Saturday, May 31, 2025

• Pragati Gole Advani, MD, DrPH, MPH, is first and presenting author, Abstract 10516 - Risk patterns for second primary malignancies among human papillomavirus (HPV)–associated first primary cancer survivors in the United States.
  • 8:35 a.m. -  E350

Monday, June 2, 2025 

• Song Yao, MD, PhD, is senior author, presenting Abstract 12014 - Trajectories of patient-reported cognitive function and age-related conditions in a longitudinal observational trial of immune checkpoint inhibitor (ICI) treatment: The DiRECT Cohort.
  • 10:25 a.m. - E450a
• Eunice S. Wang, MD, is first and presenting author, Abstract 6506 - Ziftomenib in relapsed/refractory (R/R) NPM1-mutant acute myeloid leukemia (AML): Phase 1b/2 clinical activity and safety results from the pivotal KOMET-001 study.
  • 4:35 p.m. - S100a
• Muhammad Awidi, MD, is senior author, Abstract 2511 - Safety and efficacy of immune checkpoint inhibitors in solid organ transplant recipients: A systematic review and individual patient data meta-analysis.
  • 5:18-5:20 p.m. - HAll D2

Saturday, May 31, 2025
 Hall A

9 a.m.-12 p.m.

• Ajay Gupta, MD, MS, is first and presenting author, Abstract 10032, Poster Bd 147 - Association of baseline clinical factors with outcomes in patients with localized Ewing sarcoma treated on frontline trials with interval compressed chemotherapy (ICC): A report from the Children’s Oncology Group.

1:30 p.m.-4:30 p.m.

• Pragati Gole Advani, MD, DrPH, MPH, is first/presenting author, Abstract 8037, Poster Bd 158 - Racial and ethnic disparities in risk of second primary lung cancer among initial lung cancer survivors in the United States.
• Song Yao, MD, PhD, is senior author (former fellow Arya Roy presenting), Abstract 10545, Poster Bd 270 - Genetic predictors of 16,000 multi-omic traits and associations with breast cancer survival outcomes in the Pathways Study.
• Vinit Singh, MBBS, is first/presenting author, Abstract 10616, Poster Bd 341 - Cancer genetics evaluation among individuals at risk for Lynch syndrome across all qualifying indications.
• Kriti Ahuja, MBBS, is first/presenting author, Abstract 11055, Poster Bd 394 - Development of second primary malignancies (SPMs) in head and neck cancer survivors stratified by receipt of radiation therapy (RT) and chemotherapy (CT).
• Vaishali Deenadayalan, MD, is first/presenting author, Abstract 11064, Poster Bd 403 - Impact of protein-energy malnutrition on inpatient mortality, healthcare cost and clinical outcomes among patients with head and neck cancer.
• Muhammad Awidi, MD, is first/presenting author, Abstract 11068, Poster Bd 407 - Incidence and outcomes of rejection in solid organ transplant recipients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.

Sunday, June 1, 2025 
Hall A

9 a.m.-12 p.m.

• Anuja Vidyadhar Abhyankar, MD, is first/presenting author; senior author is Marco Davila, MD, PhD, Abstract 7030, Poster Bd 213 - Effect of prophylactic corticosteroids on toxicities and outcomes in CAR T-cell therapy: A cohort study.
• Mrinalini Ramesh, DO, is first/presenting author and Deepak Vadehra, DO, is co-senior author, Abstract 1592, Poster Bd 358 - Comparative analysis of demographics and outcomes in young versus average onset hospitalized gastrointestinal cancer patients in New York State.
• Vinit Singh, MBBS, is first/presenting author, Abstract 1600, Poster Bd 366 - At-risk cancer genetic syndrome identification (ARCAGEN-ID): Novel EHR integrated system to overcome disparities in identification and testing for cancer genetic syndromes.
• Saby George, MD, is senior author, Abstract 1635, Poster Bd 401 - Experiences and preferences of cancer survivors across the immunotherapy journey.

Monday, June 2, 2025 
Hall A

9 a.m.-12 p.m.

• Elizabeth Repasky, PhD, is senior author, Abstract TPS1140, Poster Bd 109a - A phase Il trial to assess the impact of β2 adrenergic receptor (β2-AR) blockade in metastatic triple negative breast cancer (mTNBC).
• Masanori Oshi, MD, PhD, is first/presenting author, Abstract 562, Poster Bd 155 - Association of infiltration of hematopoietic stem cells (HSC) with cell proliferation and patient survival in breast cancer.
• Zunairah Shah, MD, is first/presenting author, Abstract 602, Poster Bd 195 - Racial disparities in clinical outcomes of early-stage triple-negative breast cancer treated with neoadjuvant chemoimmunotherapy: Insights from the NCDB.

1:30-4:30 p.m.

• Varsha Gupta, MD, is first/presenting author, Abstract 12041, Poster Bd 61 - Risk of non-breast cancer–related mortality in breast cancer and dependence on disease characteristics, treatment, and survival duration.
• Song Yao, MD, PhD, is first/presenting author, Abstract 12081, Poster Bd 101 - The impact of cannabis use on patient outcomes post immune checkpoint inhibitor (ICI) therapy in a longitudinal observational trial: The DiRECT Cohort.
• Yu Fujiwara, MD, is first/presenting author, Abstract 2625, Poster Bd 272 - Tumor mutational burden, PD-1, negative Wnt/β-catenin regulators, and positive MHC class II antigen presentation regulators as predictors of longer survival after immune checkpoint inhibitors across cancers: A comprehensive analysis of 400 immunity biomarkers.
• Yu Fujiwara, MD, is first/presenting author, Abstract 2642, Poster Bd 289 - Adverse events profile of novel agents targeting immune checkpoints beyond PD-1/PD-L1 and CTLA-4 in solid tumors: A meta-analysis. 

Pamela Sung, MD, PhD, is Co-Chair of Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant,

• Friday, May 30, 1-2:30 p.m. - Room E450a
   

Rohit Gosain, MD, is a presenter for three ASCO educational events and a co-host of two outside events:

• Co-presenter of SignifyMD’s “Clinicals to Exam: Oncology Board Review”
  • Thursday, May 29, 12:30-4:30 p.m. - The Wit Chicago
• “Latest Advances in Tumor-Agnostic Strategies for NTRK Fusion-Positive Cancer: Translating Science into Clinical Practice”
  • Friday, May 30, 2025; 6:45 p.m. - Hilton Chicago, International North
• Medical Education Community of Practice gathering
  • Saturday, May 31, 7:30–9:30 a.m. - Room S103
• “How I Use Social Media to Teach and Learn Oncology Updates for the Community”
  • Saturday, May 31, 3:30 p.m. - Room E350
• Co-host of Oncology Brothers event “Advancements in Oncology”
  • Saturday, May 31, 6:30-9 p.m. - Marriott Marquis Chicago

Yu Fujiwara, MD, Zunairah Shah, MD, and Vinit Singh, MBBS, all earned 2025 ASCO Annual Meeting Merit Awards. 

These awards support students and trainees who are first authors on abstracts selected for presentation at the ASCO Annual Meeting, recognizing their respective field and research advancements within the cancer care community.